Unlimited License: An Analysis of the Canadian Biotechnology Advisory Committee's Report on Patenting Higher Life Forms Archives | CCPA

Our publications are available to all at no cost. Please support the CCPA and help make important research and ideas available to everyone. Make a donation today.

Biotechnology

Health Care

Publications

Reports

National Office

Unlimited License
Public debates over controversial biotechnologies often revolve around questions about who will control them and what values will guide their development. Because patent policies shape…
April 1, 2002

Updates from the CCPA

Read the latest research, analysis and commentary on issues that matter to you.